The quantification of the relationship between the amount of microbial organisms ingested and a specific outcome such as infection, illness or mortality is a key aspect of quantitative risk assessment. A main problem in determining such dose-response models is the availability of appropriate data. Human feeding trials have been criticized because only young healthy volunteers are selected to participate and low doses, as often occurring in real life, are typically not considered. Epidemiological outbreak data are considered to be more valuable, but are more subject to data uncertainty.
The remainder of this paper is organized as follows; in Section 2, a description of the epidemiological data on Salmonella is given. Section 3 contains a (methodological) discussion on dose-illness models. In particular, GLMMs and modified fractional polynomials of dose are introduced. Application of these models with the epidemiological data on Salmonella is given in Section 4. In Section 5, bootstrap procedures are applied to account for stochastic variability as well as data uncertainty. Finally, some concluding remarks are formulated in Section 6.
Data
Data from outbreak studies reported in the risk assessment on Salmonella by the WHO [10] are used to estimate the Salmonella dose-illness relationship. In this report, 33 outbreak studies found in literature are summarized in as much detail as possible. Of these outbreak studies, 20 are selected by the WHO (2003) to be used in their quantitative risk assessment because they are sufficiently well documented. We use the data of the same 20 outbreak studies in our analyses.
For these 20 outbreak studies, the WHO (2003) report contains information with respect to the ingested dose D (log 10 CFU), the number of exposed persons N , the number of ill persons Y , serovar type t and food matrix m. In addition, distinction is made between persons belonging to the normal and the susceptible subpopulation (for definitions, see [10] ). Finally, uncertainty distributions are given for D, N and Y . These distributions are derived from additional information available on the different outbreaks. In case no such information is available to characterize uncertainty, distributions are defined of which the lower limit (resp. upper limit) is the 25% underestimate (resp. 25% overestimate) of the reported values under consideration. For more detailed information, the reader is referred to the WHO (2003) report [10] . A summary of the data is given in Table ? ?.
The outbreak number Nr and the cluster number i (will be discussed later) are displayed as well. Figure 1 , a visual representation of the data is given by means of a bubble plot of the proportion of ill subjects p = Y/N as a function of dose, with the area of the bubbles being proportional to the number of exposed subjects N . In this figure, observations on normal subjects are indicated using light gray colored bubbles with a dot indicating the middle point of the bubble whereas observations on susceptible subjects are indicated using bubbles with the darkest gray color and a star indicating the middle point.
As can be derived from the table, the Salmonella serovars S. Typhimurium and S. Enteritidis are the most prevalent in the outbreak studies under consideration. All the other Salmonella serovars occur only once. Regarding food matrix, many different types of food matrices are involved but no big differences in occurence are recorded. Furthermore, there are much more normal subjects than susceptible subjects involved in these outbreak studies. Finally, large differences in the number of exposed subjects involved in the different outbreaks can be observed, with the number of exposed subjects ranging from 1 to 7572. As can be clearly seen in Figure 1 , the number of exposed subjects is much smaller at high doses compared to low doses. As such, a proper statistical analysis should account for the differences in the number of exposed subjects as well as for heterogeneity caused by differences in host susceptibility, in serovar type and in food matrix. Other sources of heterogeneity (e.g., microflora of the food, differences in serovar strains) exist as well. Unfortunately, for the outbreak studies under consideration (WHO, 2003) , no information is available regarding these sources and as such, these sources can not be taken into account in the current analyses.
[ Figure 1 
Methodology

Dose-Illness models
Dose-illness models are still not well determined. So far, most attention is given to dose-infection models with the most popular one being the beta-poisson model [16] . This model is developed to reflect the biological process of infection, which may result from survival of a single viable pathogen and yields monotonically increasing functions of dose bounded between zero and one. Teunis et al [1] advocate that the use of the beta-poisson model to model illness as a function of dose is questionable and introduce a multiple-stage model instead, which can be graphically represented as in Figure 2 .
[ Following this model, exposure to pathogens might lead to infection and infection might lead to illness. However, note that exposure does not imply infection, nor does infection imply illness. This model is called a multiple-stage (or multiple-barrier) model since illness does not occur without infection. Hence, the probability of illness given dose equals
Whereas π(infection|dose) is typically assumed to be a monotonically increasing function of dose bounded between zero and one (e.g. beta-poisson model), some experimental evidence seems to indicate different relationships for π(ill|dose) [1] . To explain these differences, Teunis et al [1] explore three different alternatives for π(ill|infection,dose), namely (1) the increasing probability model for illness given infection, (2) the decreasing probability model and (3) the constant probability model. They assume that the probability of becoming ill depends on the duration of infection. The infection episode starts at time t = 0 when the pathogens start growing and ends at time t = τ when the pathogens have been succesfully removed by the host defense mechanisms.
As such, the length of the infection period reflects the balance between pathogen growth and host defenses. Teunis et al [1] argue that the length of the infection period may be dose-dependent.
Starting from the assumption that during infection the host has a certain probability of becoming ill and using a Gamma distribution for the duration of infection τ , Teunis et al [1] derive that the probability of illness given infection equals
with r > 0 being the shape parameter of the Gamma distribution and with λ being the integral over duration time t of the probability function for illness in an infected person. Assuming that λ varies with dose, Teunis et al [1] explore three different alternatives:
1. λ increases linearly with dose D or λ = ηD. This implies that π(ill|infection,dose) is a monotonically increasing function of dose bounded between zero and one. As such, given the common assumption that π(infection|dose) is a monotonically increasing function of dose bounded between zero and one, π(ill|dose) is also monotonically increasing as a function of dose with the same boundaries. Such a situation may arise when high initial doses of pathogens slow down the hosts defense mechanisms or, in other words, the higher the initial dose, the longer the episode of infection τ .
λ decreases with dose
decreasing function of dose bounded between zero and one. Given the common assumptions for π(infection|dose), it follows that π(ill|dose) is monotonically unconstrained with the probability of illness being zero for zero dose and infinitely large dose levels. Such a situation may arise when high initial doses of pathogens elicit strong defensive reactions of the host or, in other words, the higher the initial dose, the shorter the episode of infection τ .
3. λ is dose-independent or λ = η such that π(ill|infection,dose) = π(ill|infection). Hence, given the common assumptions for π(infection|dose), it follows that π(ill|dose) is a monotonically increasing function of dose that is bounded by zero and reaches the asymptote of π(ill|infection) < 1 for infinitely large dose levels. Such a situation suggests no facilitating nor inhibiting effects of dose on hosts defense mechanisms.
Teunis et al [1] provide real-data examples illustrating the three different probability models of illness given infection (data from [7] , [17] , [18] , respectively). In this paper, for illustrative purposes, fictive examples are given ( Figure 3 ). Clearly, different types of dose-illness relationships are possible with the properties of these relationships depending on the effect of dose on the probability of illness given infection. To summarize, the increasing probability model of illness given infection (λ = ηD) gives rise to a monotonically increasing dose-illness model bounded between zero and one (DI-I), the decreasing probability model (λ = η/D) to a monotonically unconstrained doseillness model with the probability of illness being zero for zero dose and infinitely large dose levels (DI-II) and finally, the constant probability model (λ = η) gives rise to a monotonically increasing dose-illness model bounded between zero and π(ill|infection) being some constant c < 1 (DI-III).
In the next section Generalized Linear Mixed Models (GLMMs) and fractional polynomials of dose are introduced. Different constraints on the parameters of the fractional polynomials are imposed in order to satisfy the different properties of the three types of dose-illness models.
[ Figure 3 about here.]
GLMMs and fractional polynomial of dose
Most dose-response models fit within the framework of Generalized Linear Models (GLMs) [19] .
GLMs represent a class of fixed effects regression models suited to model non-normal data (e.g.
counts, dichotomous data). However, fixed effects models, which assume that all observations are independent, are not appropriate to model clustered data. Clusters cause heterogeneity with, typically, observations belonging to the same cluster being more homogeneous compared to observations belonging to different clusters. For instance, outbreak studies in which the same food matrix is involved are more likely to be similar compared to outbreak studies in which different food matrices are involved. In case the observed clusters (e.g. clusters consisting of outbreak studies sharing the same food-matrix) are thought to represent a population of clusters, GLMs extended with cluster-specific random effects can be used. These extended models are called Generalized
Linear Mixed Models (GLMMs) (see e.g. [13] , [14] ). For instance, GLMMs with food matrixspecific random effects are suited to model the outbreak data since the food matrices involved in the recorded outbreak studies are only a sample of all possible food matrices. More formally, an example of a GLMM for the dose-illness data under consideration is
with Y ij being the number of ill subjects from observation j belonging to cluster i. The Y ij are assumed to follow a binomial distribution with parameters N ij , the number of exposed subjects, and π ij , the probability of illness. Then, the latter probality is modelled as a linear function of the known covariates dose (D ij ) and susceptibility of the population (S ij ) with corresponding fixed effects β 1 and β 2 and as a function of cluster-specific random intercepts b i ∼ N (0, σ 2 ). The linear function, also called linear predictor η ij , can take any value ranging from −∞ to +∞ whereas the probability π ij is restricted to the interval [0, 1]. Therefore, the probability π ij is transformed to the interval [−∞, +∞] using the link function g. The logit link, the complementary log-log link and the probit link are the most commonly used link functions g to transform probabilities.
In most GLMMs, the linear predictor η contains only indicator variables for discrete covariates and conventional polynomials, mostly of linear or quadratic order, for continuous covariates (like in expression (3)). However, it is recognized that the conventional polynomials do not always provide a flexible and good fit to the data. To enhance flexibility, Royston and Altman [15] introduced fractional polynomials, which are a set of parametric models offering a wide range of functional forms including the conventional polynomials. Fractional polynomial models are already been succesfully used in diverse application settings (e.g. [20] , [? ] , [21] , [22] ). A fractional polynomial of degree m for a continuous covariate x subject to the constraint x > 0, is defined as 
and with
Some examples of fractional polynomials of degree m = 2 given in Table 2 will make this clear.
As can be seen, fractional polynomials can take a wide range of functional forms. [ Table 2 about here.]
However, fractional polynomial models do not inherently satisfy the properties of the doseillness models described earlier. In case of a monotonically increasing dose-illness relationship bounded between zero and one (DI-I), a fractional polynomial of dose D of degree m = 2 can be easily modified to satisfy these properties as follows
with g −1 being the inverse of the link function g, is monotonically increasing and bounded between zero and one, which are the properties of DI-I. In case of a monotonically unconstrained dose-illness relationship with the probability of illness being zero for zero dose and infinitely large dose levels (DI-II), fractional polynomials are defined as in (5) with p 1 < 0, p 2 ≥ 0, β 1 < 0 and β 2 < 0.
These constraints imply a monotonically unconstrained function being equal to −∞ for zero dose and infinitely large dose levels. As such, g
) displays the properties of DI-II. Finally, a fractional polynomial of degree m = 1 can be modified to satisfy the properties of a monotonically increasing dose-illness model bounded between zero and some constant c < 1
with p 1 < 0 and β 1 < 0 and where g −1 (β 0 ) is an estimate of c or π(ill|infection). Table 3 displays a summary of the different constraints on the fractional polynomials of dose in order to satisfy the properties of the three different dose-illness models that are proposed by Teunis et al [1] . As can be clearly seen, the three dose-illness models share the same constraints on p 1 and β 1 . This reflects the obvious biological property that exposure is a prerequisite of illness. No illness without exposure and hence the probability of becoming ill is zero at zero dose, irrespective of the type of dose-illness model. However, the dose-illness models differ with respect to their behavior at infinitely large dose levels; the probability of illness equals 1 for DI-I, 0 for DI-II and c < 1 for DI-III.
[ Table 3 about here.]
Application to Salmonella Outbreak Data
In this section, the introduced dose-illness models are applied to the epidemiological data on Salmonella while accounting for differences in host susceptibility, in food matrices and in serovar types. Differences in host susceptibility are modeled using fixed effects since the only information we have is whether persons belong to the susceptible or the normal subpopulation. Differences in food matrix are modelled using random effects since the recorded food matrices can be seen as a sample from the population of all possible food matrices. The same holds for differences in serovar types. However, there is perfect overlap between some food matrices and serovar types (see outbreak number 1, 16 and 17 in Table 1 ) yielding an overparametrized model when both food matrix-specific and serovar type-specific random effects are incorporated in the model. A sensible alternative for modeling differences in serovar type is by means of fixed effects using the categories S. Typhimurium, S. Enteritidis and others. Statistical analysis are conducted with fixed effects for susceptibility and serovar type and random effects for food matrix. However, these analyses yield non-significant effects for serovar type due to the strong nesting of food matrix within serovar types. Another possibility is to define outbreak-specific random effects. However, in that case, the number of clusters (N r = 1, ..., 20) is almost the number of observations (n = 23). Because of data sparseness, we opt to specify random effects for the unique combinations of serovar type and food matrix. As such, the two sources of heterogeneity are taken into account but, however, they can not be separated. In total, 15 unique combinations of serovar type and food matrix (i = 1, ..., 15) are recorded (see also Table 1 ).
Hence, heterogeneity in dose-illness is accounted for using fixed effects for host susceptibility and random effects for the unique combinations of serovar type × food matrix. In particular, the following DI-I model is fitted
where D ij is the ingested dose (log 10 (CFU+ 1)) for observation j for which the unique combination of serovar type × food matrix i has been recorded, S ij is the indicator variable of host susceptibility is fitted for each population with powers p 1 and p 2 for the normal and powers p 1 and p 2 for the susceptible population. However, computation time for fractional polynomial models increases exponentially with the number of powers. Therefore, the powers p 1 and p 1 are chosen to be common for both groups whereas the powers p 2 and p 2 are chosen to be group-specific. This way, differences in host susceptibility are modeled and computation time is still kept reasonable. Power (7) is used except that different constraints on β are imposed, i.e. β 2 < 0, β 3 < 0 and β 4 < 0.
Finally, for DI-III, the following model is fitted
where D ij , S ij and b i are defined as before and where the powers p 1 and p 1 are selected from R Again constrained maximum likelihood is used to ensure the constraints on β, i.e. β 2 < 0 and
For the three different types of dose-illness models, different link functions, i.e. the logit link, the probit link and the complementary log-log link, are considered.
The best fitting models within the three types of dose-illness models are summarized in Table 4 .
Goodness-of-fit is measured by means of Aikaike's Information Criterion with small sample size correction (AICC) with the smaller its value the better the fit [23] . As can be seen, DI-III with the complementary log-log link, p 1 = −2.25 and p 1 = −0.25 fits the data best. It is investigated whether this model can be simplified. First, the null hypothesis of zero-variance for the random intercepts d 2 is tested with a mixture of X 2 distributions as reference distribution since the null hypothesis lies at the boundary of the parameter space [13] . This test yields a significant result [P (X 0:1 > 2.14) = 0.02] meaning that the heterogeneity caused by differences in the combination food matrix × serovar type are substantial. Finally, since all fixed effects are significant as well, simplification of the model is not recommended.
[ Table 4 about here.] Table ? ? gives parameter estimates and standard errors of the fixed effects β and the variance component d 2 of model (8) . Empirical bayes estimates ( [14] ) of the serovar type × food matrix-specific random intercepts b i and the corresponding standard errors are given in Table ? ?. In addition, this table contains serovar type × food matrix-specific estimates of π(ill|infection) for the normal and the susceptible population, calculated using g
respectively. Remind that π(ill|infection) is the asymptote for infinitely large dose levels. Corresponding standard errors are calculated using the delta method. As can be seen, π(ill|infection)
for the susceptible population (although mathematically < 1) is estimated to be virtually one and hence, the standard errors are undefined. For the normal population, π(ill|infection) differs strongly depending on the combination of serovar type × food matrix with values ranging from 0.303 to 0.997. These findings suggest that immunity exists in the normal population but not in the susceptible population.
Finally, graphical representations of the marginal simulation-based dose-illness relationship [14] for the normal and susceptible population are given in Figure 4 (a). However, random effects models have an interpretation conditional on the random effects implying that a marginal representation is less appropriate. Therefore, the (serovar type × food matrix)-specific dose-response relationships are calculated as well. The latter are displayed in Figure 4 (b). These figures suggest a higher probability of illness for the susceptible population compared to the normal population. However, caution is needed since the variability in estimation of the dose-response relationship and the effect of data uncertainty are not yet investigated. This is addressed in the next section.
[ Table 5 about here.]
[ Table 6 
Assessing Uncertainty
Uncertainty regarding the estimated dose-illness model is expressed by means of confidence intervals. First, a 1-stage bootstrap procedure is used to estimate confidence intervals taking into account stochastic variability only. Second, a 2-stage bootstrap procedure is constructed to estimate confidence intervals that reflect both stochastic variability as well as data uncertainty.
III with cloglog-link, p 1 = −2.25 and p 1 = −0.25 is refitted. Again, this process is repeated B times, yielding B different estimated dose-illness curves f * ( β, X) based on which the 90% pointwise confidence intervals are calculated as before. bootstrap procedure generates higher variability in estimated dose-response curves compared to the 1-stage bootstrap procedure. This is as expected because in the 2-stage bootstrap procedure stochastic variability and data uncertainty are taken into account whereas in the 1-stage bootstrap procedure only stochastic variability is accounted for. Since outbreak data are heavily subject to data uncertainty, the 2-stage bootstrap procedure, of which the results are shown in Figure ? ?, is more appropriate. Inspection of Figure ? ?, reveals large differences in (serovar × food matrix)-specific estimated curves as well as in width of the confidence intervals. For most combinations of (serovar × food matrix) and at most dose levels the difference between normal and susceptible population in estimated dose-response relationship is not significant. However, in general, the steep dose-response curves indicate a significant difference at low dose levels (e.g. Figure ? ?c, e and g) with a higher probability of illness for the susceptible population. In addition, flat dose-response curves generally indicate a significant difference at high doses (e.g. Figure ? ?b and h) with, again, a higher probability of illness for the susceptible population compared to the normal population.
Finally, when comparing the two S. Typhimurium-specific dose-response curves (e.g. Figure ? ?h and i), it is confirmed that the infectivity of a pathogen is higher when a fatty food matrix is involved [6] . The same conclusion can be drawn when comparing the two S. Enteritidis-specific curves (e.g. Figure ? ?b and c). However, in this case, it is harder to a priori judge the fattiness of the food matrices involved.
Finally, the standard errors of the (serovar × food matrix)-specific π(ill|infection) are estimated as well using both bootstrap procedures. The results are summarized in Table ? ?. This table contains only the estimates for the normal population. For the susceptible population, the bootstrap estimates π(ill|infection) are virtually always equal to < 1.000, yielding uninformative standard errors. As can be seen in the table, the standard errors obtained by 2-stage bootstrap procedure are larger compared to the ones obtained by the 1-stage bootstrap procedure, which is as expected and in line with previous findings.
[ Figure 5 about here.]
[ Figure 6 about here.]
[ Table 7 about here.] 16 differences in, amongst others, serovar strains and micorflora of the food are potential sources of heterogeneity as well. However, the available data do not contain any information on these sources and as such, they can not be taken into account in the analyses.
Nonetheless, the current application illustrates that random effects models are appropriate statistical tools to account for different sources of heterogeneity simultaneously. The analyses indicate that the Salmonella outbreak data are best described by a monotonically increasing dose-illness relationship bounded between 0 and some constant c < 1, supporting the constant probability model of illness given infection [1] . Based on confidence intervals that incorporate both stochastic variability and data uncertainty, it is concluded that the susceptible population has a higher probability of illness at low dose levels when the combination pathogen-food matrix is extremely virulent and at high dose levels when the combination is less virulent. Furthermore, the analyses suggest that immunity exists in the normal population but not in the susceptible population.
In addition, we show how bootstrapping can be used to assess the effect of data uncertainty on the estimated dose-illness relation. The 1-stage bootstrap procedure merely accounts for the usual stochastic variability. The 2-stage bootstrap procedure accounts for data uncertainty as well.
Evidently, the latter bootstrap procedure yields wider confidence intervals. However, another type of uncertainty, namely model uncertainty, is not addressed in this paper. Model uncertainty arises from the fact that several competing models might provide comparably good fits to the data and/or are equally biologically plausible. Model averaging is a way to account for model uncertainty and an example of the latter approach can be found in [24] and [25] . However, model averaging is not the focus of this manuscript. Furthermore, in case of epidemiological data compared to experimental data, data uncertainty seems much more prominent compared to model uncertainty.
Finally, the estimated dose-illness models can be used to validate quantitative risk assessments (QRAs). In case, interest is in one specific (serovar type × food matrix)-combination i of which the corresponding dose-illness model is estimated then the probability of infection given dose can be calculated using the model formulation in (7) with the estimates of β and b i given in Table 3 and 4, respectively. Then, amongst others, the delta method can be used to calculate the corresponding standard errors. As such, confidence intervals can be easily constructed to account for stochastic variability. For instance, the probability of infection for a normal person due to consumption of beef contaminated with S. Enteritidis can be calculated using g Figure 3: (a) Three different probability models of illness given infection (increasing, decreasing and constant probability) and (b) the corresponding dose-illness models. 
